Download pdf
Changes and Long-Term Effects of the Immune System after COVID-19 Infection
- 1 Urumqi Bayi middle school, Xinjiang, China
* Author to whom correspondence should be addressed.
Abstract
Following the pandemic in 2020, physical health has generally declined. All of this is brought on by modifications to the body's immune system and the consequences of sequelae. The current research gap is caused by the neglect of COVID-19's after effects. In this paper, the relationship between immune system changes, complications and their physical conditions was studied, and preliminary results on the harm and prevention of the sequelae were obtained. The immune system's alterations during the epidemic infection and its consequences are the main topics of this article, including cytokine storms, inflammatory responses, and changes in immune cells. At the same time, the article explores the relationship between complications and underlying health conditions, such as chronic diseases and autoimmune diseases, and the harm they cause. Through observation and analysis in the later stages of the epidemic, the article explores the reasons for the general decline in people's physical fitness and changes in the immune system. In the future, it is hoped that there will be improvements in disease analysis and prevention measures after pandemic diseases.
Keywords
Chronic disease, acute respiratory distress syndrome, long-term covid-19
[1]. Chen, Y., Xu, Z., Wang, P., Li, X. M., Shuai, Z. W., Ye, D. Q., & Pan, H. F. (2022). New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology, 165(4), 386-401.
[2]. Guo, M., Liu, X., Chen, X., & Li, Q. (2023). Insights into new-onset autoimmune diseases after COVID-19 vaccination. Autoimmunity Reviews, 22(7), 103340.
[3]. Hafezi, B., Chan, L., Knapp, J. P., Karimi, N., Alizadeh, K., Mehrani, Y., Bridle, B. W., & Karimi, K. (2021). Cytokine storm syndrome in SARS-CoV-2 infections: A functional role of mast cells. Cells, 10(7), 1761.
[4]. Tang, L., Yin, Z., Hu, Y., & Mei, H. (2020). Controlling cytokine storm is vital in COVID-19. Frontiers in Immunology, 11, 570993.
[5]. Fioranelli, M., Roccia, M. G., Flavin, D., & Cota, L. (2021). Regulation of inflammatory reaction in health and disease. International Journal of Molecular Sciences, 22(10), 5277.
[6]. Rodríguez, Y., Rojas, M., Beltrán, S., Polo, F., Camacho-Domínguez, L., Morales, S. D., Gershwin, M. E., & Anaya, J. M. (2022). Autoimmune and autoinflammatory conditions after COVID-19 vaccination: New case reports and updated literature review. Journal of Autoimmunity, 132, 102898.
[7]. Primorac, D., Vrdoljak, K., Brlek, P., Pavelić, E., Molnar, V., Matišić, V., Erceg Ivkošić, I., & Parčina, M. (2022). Adaptive immune responses and immunity to SARS-CoV-2. Frontiers in Immunology, 13, 848582.
[8]. Jordan, S. C., Shin, B. H., Rodriguez, E., Vo, A., Ammerman, N., & Zhang, R. (2022). Diminished T-cell immune responses to SARS-CoV-2 omicron variant after BNT162b2 vaccination. Immunology Letters, 248, 123-125.
[9]. Pruner, K. B., & Pepper, M. (2021). Local memory CD4 T cell niches in respiratory viral infection. Journal of Experimental Medicine, 218(8), e20201733.
[10]. Uddbäck, I., Michalets, S. E., Saha, A., Mattingly, C., Kost, K. N., Williams, M. E., Lawrence, L. A., Hicks, S. L., Lowen, A. C., Ahmed, H., Thomsen, A. R., Russell, C. J., Scharer, C. D., Boss, J. M., Koelle, K., Antia, R., Christensen, J. P., & Kohlmeier, J. E. (2024). Prevention of respiratory virus transmission by resident memory CD8+ T cells. Nature, 626(7998), 392-400.
[11]. Kompaniyets, L., Agathis, N. T., Nelson, J. M., Preston, L. E., Ko, J. Y., Belay, B., & Goodman, A. B. (2021). Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Network Open, 4(6), e2111182-e2111182.
[12]. Davis, H. E., McCorkell, L., Vogel, J. M., & Topol, E. J. (2023). Long COVID: Major findings, mechanisms and recommendations. Nature Reviews Microbiology, 21(3), 133-146.
[13]. Shanthanna, H., Nelson, A. M., Kissoon, N., & Narouze, S. (2022). The COVID-19 pandemic and its consequences for chronic pain: A narrative review. Anaesthesia, 77(9), 1039-1050.
[14]. Schinas, G., Polyzou, E., Mitropetrou, F., Pazionis, A., Gogos, C., Triantos, C., & Akinosoglou, K. (2022). COVID-19 vaccination in patients with chronic liver disease. Viruses, 14(12), 2778.
[15]. Polykretis, P., Donzelli, A., Lindsay, J. C., Wiseman, D., Kyriakopoulos, A. M., Mörz, M., Bellavite, P., Fukushima, M., Seneff, S., & McCullough, P. A. (2023). Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues. Autoimmunity, 56(1), 2259123.
[16]. Vnučák, M., Graňák, K., Beliančinová, M., Jeseňák, M., Macháleková, K. K., Benko, J., Samoš, M., & Dedinská, I. (2022). Acute kidney rejection after anti-SARS-CoV-2 virus-vectored vaccine-case report. NPJ Vaccines, 7(1), 30.
[17]. Saguil, A., & Fargo, M. V. (2020). Acute respiratory distress syndrome: Diagnosis and management. American Family Physician, 101(12), 730-738.
[18]. Lu, L., Liu, L. P., Gui, R., Dong, H., Su, Y. R., Zhou, X. H., & Liu, F. X. (2022). Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach. Frontiers in Immunology, 13, 975848.
[19]. Pandey, K., Thurman, M., Johnson, S. D., Acharya, A., Johnston, M., Klug, E. A., Olwenyi, O. A., Rajaiah, R., & Byrareddy, S. N. (2021). Mental health issues during and after COVID-19 vaccine era. Brain Research Bulletin, 176, 161-173.
[20]. Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., Watkinson, P., Khunti, K., Harnden, A., Coupland, C. A. C., Channon, K. M., Mills, N. L., Sheikh, A., & Hippisley-Cox, J. (2022). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nature Medicine, 28(2), 410-422.
Cite this article
Wu,Z. (2025). Changes and Long-Term Effects of the Immune System after COVID-19 Infection. Theoretical and Natural Science,69,78-84.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 3rd International Conference on Modern Medicine and Global Health
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).